These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37556911)

  • 1. Discovery of 2,4-diphenyl-substituted thiazole derivatives as PRMT1 inhibitors and investigation of their anti-cervical cancer effects.
    Zhao Z; Zhang J; Ren Y; Dong L; Wu H; Hong W; Huang H; Yang X; Pang Z; Wang H
    Bioorg Med Chem; 2023 Sep; 92():117436. PubMed ID: 37556911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Development of Tetrazole Derivatives as Protein Arginine Methyltransferase I (PRMT I) Inhibitors.
    Sun Y; Wang Z; Yang H; Zhu X; Wu H; Ma L; Xu F; Hong W; Wang H
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31390828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of novel PRMT1 inhibitors and investigation of their binding preferences using molecular modelling.
    Yang H; Ouyang Y; Ma H; Cong H; Zhuang C; Lok WT; Wang Z; Zhu X; Sun Y; Hong W; Wang H
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4635-4642. PubMed ID: 28927791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and Synthesis of Novel PRMT1 Inhibitors and Investigation of Their Effects on the Migration of Cancer Cell.
    Wang C; Dong L; Zhao Z; Zhang Z; Sun Y; Li C; Li G; You X; Yang X; Wang H; Hong W
    Front Chem; 2022; 10():888727. PubMed ID: 35755248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nη-substituted arginyl peptide inhibitors of protein arginine N-methyltransferases.
    Lakowski TM; 't Hart P; Ahern CA; Martin NI; Frankel A
    ACS Chem Biol; 2010 Nov; 5(11):1053-63. PubMed ID: 20701328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of alkyl bis(oxy)dibenzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors.
    Zhang WY; Lu WC; Jiang H; Lv ZB; Xie YQ; Lian FL; Liang ZJ; Jiang YX; Wang DJ; Luo C; Jin J; Ye F
    Chem Biol Drug Des; 2017 Dec; 90(6):1260-1270. PubMed ID: 28636189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual screening and biological evaluation of novel small molecular inhibitors against protein arginine methyltransferase 1 (PRMT1).
    Xie Y; Zhou R; Lian F; Liu Y; Chen L; Shi Z; Zhang N; Zheng M; Shen B; Jiang H; Liang Z; Luo C
    Org Biomol Chem; 2014 Dec; 12(47):9665-73. PubMed ID: 25348815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of cyanine compounds as selective inhibitors of protein arginine methyltransferases: synthesis and biological evaluation.
    Hu H; Owens EA; Su H; Yan L; Levitz A; Zhao X; Henary M; Zheng YG
    J Med Chem; 2015 Feb; 58(3):1228-43. PubMed ID: 25559100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and biochemical evaluation of bisubstrate inhibitors of protein arginine N-methyltransferases PRMT1 and CARM1 (PRMT4).
    Gunnell EA; Al-Noori A; Muhsen U; Davies CC; Dowden J; Dreveny I
    Biochem J; 2020 Feb; 477(4):787-800. PubMed ID: 32011657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule inhibitors that discriminate between protein arginine N-methyltransferases PRMT1 and CARM1.
    Dowden J; Pike RA; Parry RV; Hong W; Muhsen UA; Ward SG
    Org Biomol Chem; 2011 Oct; 9(22):7814-21. PubMed ID: 21952734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel inhibitors for PRMT1 discovered by high-throughput screening using activity-based fluorescence polarization.
    Dillon MB; Bachovchin DA; Brown SJ; Finn MG; Rosen H; Cravatt BF; Mowen KA
    ACS Chem Biol; 2012 Jul; 7(7):1198-204. PubMed ID: 22506763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel splicing isoform of protein arginine methyltransferase 1 (PRMT1) that lacks the dimerization arm and correlates with cellular malignancy.
    Patounas O; Papacharalampous I; Eckerich C; Markopoulos GS; Kolettas E; Fackelmayer FO
    J Cell Biochem; 2018 Feb; 119(2):2110-2123. PubMed ID: 28857308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer.
    Avasarala S; Van Scoyk M; Karuppusamy Rathinam MK; Zerayesus S; Zhao X; Zhang W; Pergande MR; Borgia JA; DeGregori J; Port JD; Winn RA; Bikkavilli RK
    J Biol Chem; 2015 May; 290(21):13479-89. PubMed ID: 25847239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells.
    Chuang CY; Chang CP; Lee YJ; Lin WL; Chang WW; Wu JS; Cheng YW; Lee H; Li C
    Oncol Rep; 2017 Aug; 38(2):1115-1123. PubMed ID: 28656289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity-based protein profiling of protein arginine methyltransferase 1.
    Obianyo O; Causey CP; Jones JE; Thompson PR
    ACS Chem Biol; 2011 Oct; 6(10):1127-35. PubMed ID: 21838253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLAR
    Li M; An W; Xu L; Lin Y; Su L; Liu X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):64. PubMed ID: 30736843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A protein arginine N-methyltransferase 1 (PRMT1) and 2 heteromeric interaction increases PRMT1 enzymatic activity.
    Pak ML; Lakowski TM; Thomas D; Vhuiyan MI; Hüsecken K; Frankel A
    Biochemistry; 2011 Sep; 50(38):8226-40. PubMed ID: 21851090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and optimization of selective inhibitors of protein arginine methyltransferase 5 by docking-based virtual screening.
    Ye Y; Zhang B; Mao R; Zhang C; Wang Y; Xing J; Liu YC; Luo X; Ding H; Yang Y; Zhou B; Jiang H; Chen K; Luo C; Zheng M
    Org Biomol Chem; 2017 May; 15(17):3648-3661. PubMed ID: 28397890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.
    Zhu Y; Xia T; Chen DQ; Xiong X; Shi L; Zuo Y; Xiao H; Liu L
    Drug Resist Updat; 2024 Jan; 72():101016. PubMed ID: 37980859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAM98A is a novel substrate of PRMT1 required for tumor cell migration, invasion, and colony formation.
    Akter KA; Mansour MA; Hyodo T; Ito S; Hamaguchi M; Senga T
    Tumour Biol; 2016 Apr; 37(4):4531-9. PubMed ID: 26503212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.